Skip to main content

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

PRVB holding history

Provention Bio, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRVB overviewAll 13F holders of PRVBFull Q2 2026 holdings

Shares (Q2 2023)
0
Sold out in Q2 2023
Value
$0
% of portfolio
0.0%
Quarters held
9
Since Q1 2021
Holdings of PRVB by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20230$00.0%−622,650−100.0%Sold outHolders
Q1 2023622,650$15.0M<0.1%+233,944+60.2%AddedHolders
Q4 2022388,706$4.11M<0.1%+3,194+0.8%AddedHolders
Q3 2022385,512$1.74M<0.1%+49,605+14.8%AddedHolders
Q2 2022335,907$1.34M<0.1%+69,585+26.1%AddedHolders
Q1 2022266,322$1.95M<0.1%+89,163+50.3%AddedHolders
Q4 2021177,159$996.0K<0.1%−35,858−16.8%ReducedHolders
Q3 2021213,017$1.36M<0.1%+49,006+29.9%AddedHolders
Q2 2021164,011$1.38M<0.1%+6,637+4.2%AddedHolders
Q1 2021157,374$1.65M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.